REX AI Equity Premium Income ETF vs Tempus AI — how do they compare? REX AI Equity Premium Income ETF trades at $37.3, while Tempus AI trades at $55.45 (market cap $9.93B). The key difference: REX AI Equity Premium Income ETF is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.
| AIPI | TEM | |
|---|---|---|
Sector | Income / Options Overlay | Broad Market / Factor |
52-Week High | $44.93 | $103.25 |
52-Week Low | $32.45 | $41.55 |
Market Cap | — | $9.93B |
Enterprise Value | — | $10.56B |
Signals from Pluang's Aura AI — not financial advice
AIPI trades at $37.34, up 1.52% today, with technical indicators showing a bullish trend from moving averages but neutral oscillators. The stock pays high weekly dividends, recently transitioning to this frequency to attract income investors. Key resistance lies at $38, with support at $36.
Outlook is mixed: high dividend yields near 35% offer income appeal, but sustainability concerns and structural risks from option-writing strategies pose challenges. Investors should weigh income benefits against potential NAV erosion if AI market momentum slows.
Tempus AI (TEM) trades at $52.05, up 12.86% in 24 hours, reflecting strong momentum after Q2 2026 earnings beat revenue estimates and raised 2026 sales guidance. The stock is technically bullish with moving averages supporting upside, while fundamentals show revenue growth to $1.4 billion in 2026 but persistent net losses. Recent news highlights expansion through the Personalis acquisition and AI-driven precision medicine advancements.
Outlook: Growth prospects are robust with AI adoption in healthcare and strategic deals, but high valuation ratios and negative profitability pose risks. Analysts are bullish with a $61.57 consensus target, though cash burn and competitive pressures require monitoring for sustained investor confidence.
Trailing returns across standard periods
AIPI provides exposure to leading artificial intelligence firms while seeking to generate monthly income. It uses a covered call strategy to capture premiums from the volatility of AI-related stocks.
Read more on AIPI →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →